SourceBio International PLC Director/PDMR Shareholding (5656U)

TIDMSBI

RNS Number : 5656U

SourceBio International PLC

03 December 2021

3 December 2021

SourceBio International plc

(" SourceBio", the "Company" or the "Group")

Director/PDMR Shareholding

SourceBio International plc ("the Company") has been notified that today, Harwood Capital LLP has transferred in aggregate 94,743 ordinary shares of 0.15 pence each in the Company ("Ordinary Shares") to the Limited Partners of Harwood Private Equity IV L.P. ("HPE4") in order to satisfy distributions, in the normal course of business. Christopher Mills, Non-Executive Director of the Company is Chief Executive of Harwood Capital LLP.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1     Details of the person discharging managerial responsibilities 
        / person closely associated 
 a)    Name                                      Harwood Capital LLP as investment 
                                                  manager 
      ---------------------------------------  ------------------------------------------- 
 2     Reason for the notification 
      ------------------------------------------------------------------------------------ 
 a)    Position/status                          Christopher Mills is a non-executive 
                                                 director of the issuer and Chief 
                                                 Executive of the investment manager 
      ---------------------------------------  ------------------------------------------- 
 b)    Initial notification                     Initial Notification 
        /Amendment 
      ---------------------------------------  ------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
      ------------------------------------------------------------------------------------ 
 a)    Name                                     SourceBio International Plc 
      ---------------------------------------  ------------------------------------------- 
 b)    LEI                                      213800KY4C9WU7WBW518 
      ---------------------------------------  ------------------------------------------- 
 4     Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      ------------------------------------------------------------------------------------ 
 a)    Description of the                       Ordinary shares of GBP0.0015 each 
        financial instrument, 
        type of instrument 
 
       Identification code                      GB00BKSB1674 
 
 b)    Nature of the transaction                Transfer of shares 
      ---------------------------------------  ------------------------------------------- 
 c)    Price(s) and volume(s) 
                                                -------------------  ------------------- 
                                                 Price(s)             Volume(s) 
                                                -------------------  ------------------- 
    Nil                                                               94,743 
   ----------------------------------------------------------------  ------------------- 
 
 d)    Aggregated information                   N/A - single transaction 
 
  Volume 
  Price 
 e)    Date of the transaction                                   3 December 2021 
 f)    Place of the transaction                 Off market 
      ---------------------------------------  ------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFISFLLVIIL

(END) Dow Jones Newswires

December 03, 2021 09:02 ET (14:02 GMT)